Annual Total Expenses
$16.94 M
-$4.91 M-22.45%
December 31, 2023
Summary
- As of February 7, 2025, VRPX annual total expenses is $16.94 million, with the most recent change of -$4.91 million (-22.45%) on December 31, 2023.
- During the last 3 years, VRPX annual total expenses has risen by +$12.74 million (+303.74%).
- VRPX annual total expenses is now -22.45% below its all-time high of $21.85 million, reached on December 31, 2022.
Performance
VRPX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$1.92 M
-$1.53 M-44.36%
September 30, 2024
Summary
- As of February 7, 2025, VRPX quarterly total expenses is $1.92 million, with the most recent change of -$1.53 million (-44.36%) on September 30, 2024.
- Over the past year, VRPX quarterly total expenses has dropped by -$4.19 million (-68.53%).
- VRPX quarterly total expenses is now -75.06% below its all-time high of $7.72 million, reached on September 30, 2022.
Performance
VRPX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
VRPX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.4% | -68.5% |
| 3 y3 years | +303.7% | -40.8% |
| 5 y5 years | +545.1% | -40.8% |
VRPX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.4% | +40.9% | -75.1% | +16.6% |
| 5 y | 5-year | -22.4% | +432.4% | -75.1% | +212.4% |
| alltime | all time | -22.4% | +545.1% | -75.1% | +212.4% |
Virpax Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.92 M(-44.4%) |
| Jun 2024 | - | $3.46 M(+4.7%) |
| Mar 2024 | - | $3.30 M(-44.3%) |
| Dec 2023 | $16.94 M(-22.5%) | $5.93 M(-3.0%) |
| Sep 2023 | - | $6.12 M(+88.8%) |
| Jun 2023 | - | $3.24 M(+96.2%) |
| Mar 2023 | - | $1.65 M(-46.8%) |
| Dec 2022 | $21.85 M | $3.10 M(-59.8%) |
| Sep 2022 | - | $7.72 M(+30.7%) |
| Jun 2022 | - | $5.90 M(+15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $5.12 M(+24.3%) |
| Dec 2021 | $12.03 M(+186.6%) | $4.12 M(+26.8%) |
| Sep 2021 | - | $3.25 M(+41.0%) |
| Jun 2021 | - | $2.31 M(-1.8%) |
| Mar 2021 | - | $2.35 M(+241.9%) |
| Dec 2020 | $4.20 M(+31.9%) | $686.90 K(-58.7%) |
| Sep 2020 | - | $1.66 M(+35.1%) |
| Jun 2020 | - | $1.23 M(+99.8%) |
| Mar 2020 | - | $615.90 K(-7.1%) |
| Dec 2019 | $3.18 M(+21.2%) | $663.30 K |
| Dec 2018 | $2.63 M | - |
FAQ
- What is Virpax Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual total expenses year-on-year change?
- What is Virpax Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly total expenses year-on-year change?
What is Virpax Pharmaceuticals annual total expenses?
The current annual total expenses of VRPX is $16.94 M
What is the all time high annual total expenses for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual total expenses is $21.85 M
What is Virpax Pharmaceuticals annual total expenses year-on-year change?
Over the past year, VRPX annual total expenses has changed by -$4.91 M (-22.45%)
What is Virpax Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of VRPX is $1.92 M
What is the all time high quarterly total expenses for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly total expenses is $7.72 M
What is Virpax Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, VRPX quarterly total expenses has changed by -$4.19 M (-68.53%)